2PandaA, AhujaR, BiswasNR, etal. Role of 0.02% polyhexamethylene biguanide and 1 % povidone iodine in experimental Aspergillus keratitis. Cornea, 2003, 22(2):138-141.
3Schreiber W, Olbrisch A, Vorwerk CK, et al. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci, 2003, 44(6):2634-2643.
4Burda CD, Fisher E Jr. The use of cortisone in establishing experimental fungal keratitis in rats. Am J Ophthalmol, 1959, 48: 330-335.
5Tseng SH, Tang KY, Chao SC, et al. Therapeutic lamellar keratectomy in the management of experimental keratomycosis. J Formos Med Assoc, 1994, 93(4):300-306.
6Wu TG, Wilhelmus KR, Mitchell BM. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci, 2003, 44 ( 1 ): 210-216.
7Garcia ML, HerrerasJM, DiosE, et al. Evaluation of lectin staining in the diagnosis of fungal keratitis in an experimental rabbit model.Mol Vis, 2002, 8:10-16.
8Kiryu H, Yoshida S, Suenaga Y, et al. Invasion and survival of Fusarium solani in the dexamethasone-treated cornea of rabbits. J Med Vet. Mycol, 1991, 29(6) :395-406.
9O'Day DM, Head WS, Csank C, et al. Differences in virulence between two Candida albicans strains in experimental keratitis. Invest Ophthalmol Vis Sci, 2000, 41(5): 1116-1121.
10Gopinathan U, Ramakrishna T, Willcox M, et al. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. Exp Eye Res, 2001, 72(4) :433-442.
